Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CSPC Pharmaceutical Group Limited Earnings Release 2003

Mar 22, 2004

49680_rns_2004-03-22_5eec70d3-411c-418d-9c33-3797c521035e.htm

Earnings Release

Open in viewer

Opens in your device viewer

Listed Company Information

CHINA PHARMA<01093> - Results Announcement (Summary)

China Pharmaceutical Group Limited announced on 22/3/2004:
(stock code: 01093 )
Year end date: 31/12/2003
Currency: HKD
Auditors' Report: Unqualified

(Audited )
(Audited ) Last
Current Corresponding
Period Period
from 1/1/2003 from 1/1/2002
to 31/12/2003 to 31/12/2002
Note ('000 ) ('000 )
Turnover : 2,478,426 1,625,130
Profit/(Loss) from Operations : 618,289 297,891
Finance cost : (25,361) (26,682)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : 7,610 7,916
Profit/(Loss) after Tax & MI : 504,169 228,142
% Change over Last Period : +121 %
EPS/(LPS)-Basic (in dollars) : 0.3327 0.1662
-Diluted (in dollars) : 0.3283 0.1635
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 504,169 228,142
Final Dividend : HK 7.0 cents HK 6.0 cents
per Share
(Specify if with other : N/A N/A
options)

B/C Dates for
Final Dividend : 10/5/2004 to 14/5/2004 bdi.
Payable Date : 28/5/2004
B/C Dates for Annual
General Meeting : 10/5/2004 to 14/5/2004 bdi.
Other Distribution for : N/A
Current Period

B/C Dates for Other
Distribution : N/A

Remarks:


1. Profit from operations
2003 2002
HK$'000 HK$'000
Profit from operations has been arrived
at after charging (crediting):

Amortisation of intangible assets 13,770 14,303
Amortisation of goodwill 3,168 1,546
Depreciation of property, plant and equipment 129,024 103,818
Impairment of intangible assets 10,878 -
Bank interest income (1,589) (1,737)
======== ========
2. Earnings per share

The calculation of the basic and diluted earnings per share is based on
the following data:
2003 2002

Profit attributable to shareholders HK$504,169,000 HK$228,142,000
================= ==============
Weighted average number of ordinary
shares for the purposes of basic
earnings per share 1,515,192,387 1,373,033,290

Effect of dilutive potential ordinary
shares in respect of share options 20,501,401 22,612,855
----------------- -------------
Weighted average number of ordinary
shares for the purposes of diluted
earnings per share 1,535,693,788 1,395,646,145
================= =============